Search Results - Frieder Fuchs

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    In vitro Activity of Repurposed Nitroxoline Against Clinically Isolated Mycobacteria Including Multidrug-Resistant Mycobacterium tuberculosis by Ada Marie Hoffmann, Martina Wolke, Jan Rybniker, Jan Rybniker, Georg Plum, Frieder Fuchs, Frieder Fuchs

    Published in Frontiers in Pharmacology (2022-05-01)
    Get full text
    Article


  2. 2

    Activity of the old antimicrobial nitroxoline against Mycobacterium abscessus complex isolates by Ada Marie Hoffmann, Martina Wolke, Jan Rybniker, Georg Plum, Frieder Fuchs

    Published in Journal of Global Antimicrobial Resistance (2023-06-01)
    Get full text
    Article


  3. 3

    Molecular Epidemiology of <i>Escherichia coli</i> with Resistance against Third-Generation Cephalosporines Isolated from Deployed German Soldiers—A Retrospective Assessment after D... by Frederik Pankok, Frieder Fuchs, Ulrike Loderstädt, Martin Kaase, Carsten Balczun, Simone Scheithauer, Hagen Frickmann, Ralf Matthias Hagen

    Published in Microorganisms (2022-12-01)
    Get full text
    Article


  4. 4

    Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment by Javier Chao-Pellicer, Iñigo Arberas-Jiménez, Frieder Fuchs, Ines Sifaoui, José E. Piñero, Jacob Lorenzo-Morales, Patrick Scheid

    Published in Antibiotics (2023-08-01)
    Get full text
    Article


  5. 5

    Coexistence of seven different carbapenemase producers in a single hospital admission screening confirmed by whole-genome sequencing by Frieder Fuchs, Kyriaki Xanthopoulou, Tessa Burgwinkel, Rocío Arazo del Pino, Esther Wohlfarth, Florian Pavlu, Ralf M. Hagen, Paul G. Higgins

    Published in Journal of Global Antimicrobial Resistance (2024-12-01)
    Get full text
    Article


  6. 6

    Toxigenic Corynebacterium diphtheriae–Associated Genital Ulceration by Frieder Fuchs, Derya Markert, Isabel V. Wagner, Max C. Liebau, Anja Berger, Alexandra Dangel, Andreas Sing, Mario Fabri, Georg Plum

    Published in Emerging Infectious Diseases (2020-09-01)
    Get full text
    Article


  7. 7

    Repurposing Analysis of Nitroxoline (8-Hydroxy-5-nitroquinoline) as an Antichagasic Compound by Carlos J. Bethencourt-Estrella, Atteneri López-Arencibia, Isabel M. Calero-Docina, Frieder Fuchs, Patrick Scheid, Jacob Lorenzo-Morales, José E. Piñero

    Published in Pharmaceuticals (2025-07-01)
    Get full text
    Article


  8. 8

    A Case of <i>Pseudomonas straminea</i> Blood Stream Infection in an Elderly Woman with Cellulitis by Leopold Böhm, Marius Eberhardt Schaller, Carsten Balczun, Andreas Krüger, Timo Schummel, Alexander Ammon, Niklas Klein, Dario Lucas Helbing, Rüdiger Eming, Frieder Fuchs

    Published in Infectious Disease Reports (2024-07-01)
    Get full text
    Article


  9. 9

    Cross-Sectional Assessment on Carbapenem-Resistant Gram-Negative Bacteria Isolated from Patients in Moldova by Vadim Nirca, Frieder Fuchs, Tessa Burgwinkel, Rocío Arazo del Pino, Ecaterina Zaharcenco, Ralf Matthias Hagen, Sven Poppert, Hagen Frickmann, Paul G. Higgins

    Published in Microorganisms (2025-02-01)
    Get full text
    Article


  10. 10

    Induction of Programmed Cell Death in <i>Acanthamoeba culbertsoni</i> by the Repurposed Compound Nitroxoline by Rubén L. Rodríguez-Expósito, Ines Sifaoui, María Reyes-Batlle, Frieder Fuchs, Patrick L. Scheid, José E. Piñero, Robert Sutak, Jacob Lorenzo-Morales

    Published in Antioxidants (2023-12-01)
    Get full text
    Article


  11. 11

    High genetic relatedness between multidrug resistant bacteria before and after the 2022 invasion of Ukraine by Francois Lebreton, Viacheslav Kondratiuk, Valentyn Kovalchuk, Niels Pfennigwerth, Ting L. Luo, Brendan T. Jones, Nadiia Fomina, Frieder Fuchs, Jörg B. Hans, Jessica Eisfeld, Ana Ong, Sören Gatermann, Jason W. Bennett, Patrick Mc Gann

    Published in Genome Medicine (2025-07-01)
    Get full text
    Article


Search Tools: